ID: ALA3617316

Max Phase: Preclinical

Molecular Formula: C6H4N4O3

Molecular Weight: 180.12

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(O)c1cn2cnnc2nc1O

Standard InChI:  InChI=1S/C6H4N4O3/c11-4-3(5(12)13)1-10-2-7-9-6(10)8-4/h1-2H,(H,12,13)(H,8,9,11)

Standard InChI Key:  XUWOCPJRQIPGIJ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 180.12

Molecular Weight (Monoisotopic): 180.0283

AlogP: -0.47

#Rotatable Bonds: 1

Polar Surface Area: 100.61

Molecular Species: ACID

HBA: 6

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.41

CX Basic pKa: 1.42

CX LogP: -0.67

CX LogD: -3.96

Aromatic Rings: 2

Heavy Atoms: 13

QED Weighted: 0.61

Np Likeness Score: -1.48

References

1. Katane M, Yamada S, Kawaguchi G, Chinen M, Matsumura M, Ando T, Doi I, Nakayama K, Kaneko Y, Matsuda S, Saitoh Y, Miyamoto T, Sekine M, Yamaotsu N, Hirono S, Homma H..  (2015)  Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.,  58  (18): [PMID:26322531] [10.1021/acs.jmedchem.5b00871]

Source

Source(1):

• Scientific Literature